Project Grant HT94252410614
Award Date
8/1/24
Completion Date
7/31/27
Dollars Obligated
$706K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Great Britain, United Kingdom
Similar Awards
This $376,037 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Birmingham in the United Kingdom. The project aims to develop a real-time assessment of retinal perfusion and blood flow as a surrogate measure for cerebral perfusion in severe traumatic brain injury. This advanced medical research project will investigate innovative diagnostic techniques to better understand...
This $2,699,157 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a research initiative focused on evaluating the effectiveness of a traumatic brain injury whole blood test in improving assessment and triage for patients with mild traumatic brain injury presenting to civilian emergency departments. The project will be conducted by the University of Pittsburgh, a prominent public research university,...
This $569,851 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research on the "Effectiveness of the Traumatic Brain Injury Whole Blood Test on Improving Assessment and Triage for Patients with Mild Traumatic Brain Injury Presenting to Civilian Emergency Departments." The University of Pittsburgh, a major public research university, is the prime recipient for this 4-year grant running from July 1, 2025...
The University of Alabama at Birmingham (UAB) was awarded a $2,069,849 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support UAB's research from May 1, 2023 to April 30, 2027 to understand cardiovascular disease in mental health and stress disorders. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...
The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...
The University of Alabama at Birmingham (UAB) received a $724,115 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The purpose of this 3-year grant, awarded on September 1, 2024, is to conduct research on the utility of sodium nitrite in improving recovery after spinal cord injuries. As a leading research institution, UAB will leverage its expertise in biomedical engineering, neuroscience, and clinical trials to...
The University of Alabama at Birmingham (UAB) received a $1,139,184.00 Project Grant award from the Defense Health Agency for the research project "MORE EFFECTIVE, KEEPING IT SAFE: REPEAT OHSV TREATMENT FOR GLIOMA". The award, which began on August 15, 2023 and is scheduled for completion on August 14, 2027, is funded through the Military Medical Research and Development program (CFDA 12.420). This grant supports UAB's biomedical research efforts to transform health care for Service...
The University of Alabama at Birmingham will use a $148,500 Project Grant from the Defense Health Agency to support research titled "SMART-BASED REPAIR OF NF1 PRE-MRNA." The grant is part of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions. Specifically, the university will investigate medical solutions for the battlefield by exploring RNA-based therapies to...
The Project Grant award, titled "PROGRAM TO CHARACTERIZE EVOLVING ENDOPHENOTYPES OF DEGENERATION AFTER TRAUMATIC BRAIN INJURY (PROCEED-TBI)", was provided by the Defense Health Agency for $7,956,997.00 with a period of performance from September 30, 2023 to September 29, 2027. The grant supports biomedical research related to the Military Medical Research and Development program (CFDA 12.420), with a focus on characterizing clinically relevant animal models of traumatic brain injury...
This federal Project Grant award for $4,343,333.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development and validation of patient-reported outcome measures (PROMs), clinical outcome measures, natural history studies, and interventions targeting mild traumatic brain injury-related vision disorders. The award, effective from September 30, 2024 to September 29, 2028, will be carried out by Drexel University, a...